Search the web
Welcome, Guest
[Sign Out, My Account]

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
SMA > SEC Filings for SMA > Form 8-K on 2-Jan-2014All Recent SEC Filings

Show all filings for SYMMETRY MEDICAL INC.



Entry into a Material Definitive Agreement, Financial Statements and Exhibi

Item 1.01 Entry Into A Material Definitive Agreement

As reported in the Company's December 27, 2013 press release, Symmetry Medical, Inc. has entered into an Omnibus Amendment No. 3 to Credit Agreement, Amendment No. 1 to Subsidiary Guaranty, Consent and Waiver (the "Amendment"). The Amendment enables the Company to pay down its mezzanine debt, otherwise due December 2017, using its existing $200.0 million senior secured revolving credit facility. The Company's payment of the mezzanine debt is effective December 27, 2013, and consists of equal payments of $36,204,563 to each of its mezzanine lenders, JPM Mezzanine Capital, LLC and GSO Blackstone Debt Funds Management,
LLC. The Company anticipates that lower interest payments associated with the elimination of the higher rate mezzanine debt will be approximately $0.10 accretive to 2014 earnings per share.

The Amendment also updates the Company's total leverage ratio covenant as follows: 4.00x through the fourth quarter 2013 and first quarter 2014; 3.75x through second quarter 2014; 3.50x through fourth quarter 2014; and 3.25x thereafter as well as amends the agreed approach to calculating adjusted EBITDA for certain clarifications and modifications. The Amendment amends the guaranty agreements of the Company's subsidiaries to include an obligation on the part of each guarantor, subject to certain limitations, to provide funds to each other guarantor to the extent required to enable that guarantor to discharge its guaranty obligations with respect to certain swap obligations under the Credit Agreement. Also, as part of the Amendment, the Company's lenders agreed to waive any default or potential default related to the Company's subsidiary, Clamonta Limited, through the earlier of March 31, 2015 and the date that the book value of Clamonta's assets is at least $7.5 million, and consented to a reorganization of the Company's German subsidiary.

The foregoing summary is qualified in its entirety by the Amendment which is filed herewith as Exhibit 10.1 and the press release filed as exhibit 99.1.

Item 9.01. Financial Statements and Exhibits

(d) Exhibits:

10.1 Omnibus Amendment No. 3 to Credit Agreement, Amendment No. 1 to Subsidiary Guaranty, Consent and Waiver

Press Release entitled, "Symmetry Medical Amends Credit Agreement and
99.1 Eliminates Mezzanine Debt," issued December 27, 2013

  Add SMA to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for SMA - All Recent SEC Filings
Copyright © 2015 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.